Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiation. by Matthew Prideaux, Nigel Loveridge, Andrew A Pitsillides, Colin Farquharson

Get full text

Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies by Timothy J. Dreyer, Jacob A. C. Keen, Leah M. Wells, Mark Hopkinson, Isabel R. Orriss, Gill Holdsworth, Andrew A. Pitsillides, Scott J. Roberts

Get full text

Deficiency and Also Transgenic Overexpression of Timp-3 Both Lead to Compromised Bone Mass and Architecture In Vivo. by Behzad Javaheri, Mark Hopkinson, Blandine Poulet, Andrea S Pollard, Sandra J Shefelbine, Yu-Mei Chang, Philippa Francis-West, George Bou-Gharios, Andrew A Pitsillides

Get full text

Temporomandibular joint degeneration arises spontaneously in STR/ort mice and is prevented by targeted aggrecanase inhibition by Kazuhiro Ooi, Kazuhiro Yamamoto, Yutaka Kobayashi, Behzad Javaheri, Anders Jensen, Ioannis Kanakis, Takao Sakai, Fadi Jarad, Hiroyuki Nakamura, Andrew A. Pitsillides, Shuichi Kawashiri, George Bou-Gharios

Get full text

Overexpression of TIMP-3 in Chondrocytes Produces Transient Reduction in Growth Plate Length but Permanently Reduces Adult Bone Quality and Quantity. by Blandine Poulet, Ke Liu, Darren Plumb, Phoung Vo, Mittal Shah, Katherine Staines, Alexandra Sampson, Hiroyuki Nakamura, Hideaki Nagase, Alessandra Carriero, Sandra Shefelbine, Andrew A Pitsillides, George Bou-Gharios

Get full text

A multi-model approach identifies ALW-II-41-27 as a promising therapy for osteoarthritis-associated inflammation and endochondral ossification by Mauricio N. Ferrao Blanco, Raphaelle Lesage, Nicole Kops, Niamh Fahy, Fjodor T. Bekedam, Athina Chavli, Yvonne M. Bastiaansen-Jenniskens, Liesbet Geris, Mark G. Chambers, Andrew A. Pitsillides, Roberto Narcisi, Gerjo J.V.M. van Osch

Get full text